Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

BHF Oxford Centre of Research Excellence (BHF Oxford CRE)

The BHF Oxford CRE unites the University’s cross-disciplinary cardiovascular research community, from discovery science through to clinical and population health research, and aims to drive innovation with rapid translational potential.

The Centre has three core Research Themes and includes over 70 individual Principal Investigators and their research groups across the University. The three selected focal areas for the BHF Oxford CRE are Big Data & Computational Science, Repair & Regeneration and Drug Discovery & Delivery which draw on multiple disciplines to advance cardiovascular sciences and benefits for patients.

BHF Oxford CRE themes © University of Oxford

Aims & ambitions of the BHF Oxford Centre of Research Excellence:

  • Build cross-disciplinary links across biological sciences with chemistry, mathematics, computational and engineering sciences. Leverage scientific excellence, and capabilities to address new areas of research, incorporating physical sciences and discovery research, through clinical studies, to population science
  • Attract, retain and support new researchers in order to bring in expertise from other disciplines, and nurture the leading cardiovascular scientists of the future
  • Train and support early- and mid-career researchers, building diversity and inclusivity and ensuring future leadership succession
  • Promote a renewed focus on research leading to innovations, co-generation of IP and commercialisation, as a route to clinical translation, guided by new internal and external advisors in entrepreneurship and commercialisation
  • Drive institutional prioritisation of research on heart and circulatory diseases to leverage strategic-level funding, and build relationships with external partners, including the NHS and industry, that enable translation to patient benefit
  • Develop our partnerships with other research consortia, patients and the public, across all areas of heart and circulatory diseases
  • To become the leading UK Centre for cardiovascular research and amongst the leading cardiovascular Centres worldwide.